Related Experiment Video
Updated: Jan 20, 2026

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
Minimal Requirements for Primary HIV Latency Models Based on a Systematic Review
Pawel Bonczkowski1, Marie-Angélique De Scheerder1, Ward De Spiegelaere1
1HIV Translational Research Unit, Department of Internal Medicine, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent, Belgium.
This review compares in vitro primary models for studying the human immunodeficiency virus type 1 (HIV-1) reservoir. It identifies commonalities and minimal requirements for developing robust HIV-1 latency models.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Studying the human immunodeficiency virus type 1 (HIV-1) reservoir is crucial for eradication efforts.
- In vitro primary latency models are essential due to the scarcity of latently infected cells in patients.
- Existing models vary in cell type, HIV strains, activation methods, and latency assessment.
Purpose of the Study:
- To systematically review and compare existing in vitro primary HIV-1 latency models.
- To identify the minimal requirements for establishing effective HIV-1 latency studies.
- To propose a generalized workflow for in vitro HIV-1 latency model development.
Main Methods:
- Systematic literature search of PubMed and Web of Science databases.
- Identification and analysis of 17 unique publications proposing novel in vitro latency models.
- Comparative analysis of model characteristics including cell types, HIV strains, activation, and readout strategies.
Main Results:
- A wide range of methodologies exist for in vitro HIV-1 latency models.
- Common characteristics and critical decision points were identified across different models.
- A generalized workflow encompassing cell selection to model readout was proposed.
Conclusions:
- Standardizing key elements in HIV-1 latency models can improve comparability and reproducibility.
- The proposed workflow provides a framework for developing and validating new in vitro models.
- Further research is needed to optimize minimal requirements for robust HIV-1 latency studies.
Related Concept Videos
06:09P300-Based Brain-Computer Interface Speller Performance Estimation with Classifier-Based Latency Estimation
07:18High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:10Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
11:38Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
07:39An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
11:10Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

